Skip to main content
Dr. Reddy's Laboratories Limited (NSE: DRREDDY)
India flag India · Delayed Price · Currency is INR
1,302.35
-7.05 (-0.54%)
Jan 20, 2025, 3:30 PM IST

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 80.16B INR in the quarter ending September 30, 2024, with 16.51% growth. This brings the company's revenue in the last twelve months to 299.87B, up 12.37% year-over-year. In the fiscal year ending March 31, 2024, Dr. Reddy's Laboratories had annual revenue of 279.16B with 13.54% growth.

Revenue (ttm)
299.87B
Revenue Growth
+12.37%
P/S Ratio
n/a
Revenue / Employee
11.09M
Employees
27,048
Market Cap
1,079.93B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020174.60B20.75B13.49%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 503.08B
Divi's Laboratories 86.14B
Cipla 262.64B
Mankind Pharma 110.18B
Zydus Lifesciences 214.84B
Apollo Hospitals Enterprise 204.69B
Aurobindo Pharma 302.95B
Alkem Laboratories 128.32B
Revenue Rankings

Dr. Reddy's Laboratories News

More News